• Success Stories
• Research
• Latest News
• Users
• Intro to Paleo
  • Paleo for Beginners
    繁體中文
  • PaleoQ™
  • Paleo Diet Resources
• About Us
  • Mission
    
  • Paleo for Life Blog
  • Contact Us

Paleo Diet for Coronary Artery Disease

rated 0.0 out of 5 , based on 0 reviews.

Success stories and experiences on how the Paleo Diet has helped with Coronary Artery Disease.

From the Paleosphere

• If you have coronary artery disease . . . do you know why?. The Heart Scan Blog September 9, 2006
• Coronary Artery Disease and Vitamin D. NephroPal August 23, 2009
• Renal Artery Stenosis. NephroPal July 30, 2009
• Apolipoprotein- B But not LDL Cholesterol Linked to Artery Calcium Build Up. Diabetes Update (cites 1 article) July 31, 2009
• Coronary calcium: Cause or effect?. The Heart Scan Blog (cites 1 article) November 28, 2010
• "You can't reduce coronary plaque". The Heart Scan Blog May 10, 2009
• Osteoporosis and coronary calcium. The Heart Scan Blog March 3, 2008
• Coronary arteries aren't what they seem. The Heart Scan Blog November 12, 2007
• Homocysteine and coronary plaque. The Heart Scan Blog April 7, 2007
• Vitamin K2 and coronary plaque. The Heart Scan Blog April 4, 2007
• What if I had a cure for coronary disease?. The Heart Scan Blog October 28, 2006
• If you get a 64-slice CT coronary angiogram. The Heart Scan Blog July 3, 2006
• Coronary disease is drying up!. The Heart Scan Blog April 7, 2006
• Fructose is a coronary risk factor. The Heart Scan Blog August 4, 2009
• The Coronary Heart Disease Epidemic. Whole Health Source May 13, 2009
• CT coronary angiography is NOT a screening procedure. The Heart Scan Blog November 28, 2008
• The myth of mild coronary disease. The Heart Scan Blog January 19, 2008
• Risks for coronary disease 2008. The Heart Scan Blog December 30, 2007
• Erectile dysfunction and coronary plaque. The Heart Scan Blog May 6, 2007
• Catheterization to “define coronary anatomy”. The Heart Scan Blog July 10, 2006
• Vitamin D--A coronary risk factor. The Heart Scan Blog May 27, 2006
• Luminations: Coronary Luminology, Lipids, Laughs. Animal Pharm (cites 5 articles) September 24, 2008
• The Coronary Heart Disease Epidemic: Possible Culprits Part II. Whole Health Source May 20, 2009
• The Coronary Heart Disease Epidemic: Possible Culprits Part I. Whole Health Source (cites 5 articles) May 17, 2009
• Latest Study on Vitamin K and Coronary Heart Disease. Whole Health Source (cites 2 articles) March 7, 2009
• A curious case of coronary plaque regression and progression. The Heart Scan Blog September 18, 2006
• Pre-diabetes: An explanation for explosive coronary plaque growth. The Heart Scan Blog May 31, 2006
• New Cordain Publication: Dietary fat quality and coronary heart disease prevention. Primal Wisdom October 1, 2009

Research References

• Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. J. Nutr. 2004 Nov;134(11):3100-5. (cited by 9 analyses) March 2012
• Dietary fats, carbohydrate, and progression of coronary atherosclerosis in postmenopausal women. Am. J. Clin. Nutr. 2004 Nov;80(5):1175-84. (cited by 8 analyses) May 2013
• High dietary menaquinone intake is associated with reduced coronary calcification. Atherosclerosis 2009 Apr;203(2):489-93. (cited by 4 analyses) April 2012
• Progression of coronary artery calcium and risk of first myocardial infarction in patients receiving cholesterol-lowering therapy. Arterioscler. Thromb. Vasc. Biol. 2004 Jul;24(7):1272-7. (cited by 3 analyses) September 2009
• A high menaquinone intake reduces the incidence of coronary heart disease. Nutr Metab Cardiovasc Dis 2009 Sep;19(7):504-10. (cited by 3 analyses) May 2010
• Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA 2006 Apr 5;295(13):1556-65. (cited by 3 analyses) July 2009
• Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet 1994 Jun 11;343(8911):1454-9. (cited by 3 analyses) June 2009
• Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 2007 Mar 31;369(9567):1090-8. (cited by 3 analyses) October 2008
• Effect of intensive versus standard lipid-lowering treatment with atorvastatin on the progression of calcified coronary atherosclerosis over 12 months: a multicenter, randomized, double-blind trial. Circulation 2006 Jan 24;113(3):427-37. (cited by 3 analyses) November 2007
• Vitamin B12 deficiency is associated with coronary artery disease in an Indian population. Clin. Chem. Lab. Med. 2009;47(3):334-8. (cited by 2 analyses) January 2011
• Saturated fat prevents coronary artery disease? An American paradox. Am. J. Clin. Nutr. 2004 Nov;80(5):1102-3. (cited by 2 analyses) February 2012
• Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N. Engl. J. Med. 2008 Mar 27;358(13):1336-45. (cited by 2 analyses) September 2008
• Fetal programming of coronary heart disease. Trends Endocrinol. Metab. 2002 Nov;13(9):364-8. (cited by 2 analyses) May 2012
• Dietary fat intake and the risk of coronary heart disease in women. N. Engl. J. Med. 1997 Nov 20;337(21):1491-9. (cited by 3 analyses) December 2009
• Relation between blood glucose and coronary mortality over 33 years in the Whitehall Study. Diabetes Care 2006 Jan;29(1):26-31. (cited by 2 analyses) November 2010
• Dietary fat and risk of coronary heart disease in men: cohort follow up study in the United States. BMJ 1996 Jul 13;313(7049):84-90. (cited by 3 analyses) January 2011
• Relationship between n-3 and n-6 plasma fatty acid levels and insulin resistance in coronary patients with and without metabolic syndrome. Nutr Metab Cardiovasc Dis 2009 May;19(4):264-70. (cited by 2 analyses) September 2012
• The effect of dietary omega-3 fatty acids on coronary atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. 1999 Apr 6;130(7):554-62. (cited by 2 analyses) June 2009
• Red and processed meat consumption and risk of incident coronary heart disease, stroke, and diabetes mellitus: a systematic review and meta-analysis. Circulation 2010 Jun 1;121(21):2271-83. (cited by 2 analyses) April 2013
• Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia. Circ. J. 2002 Dec;66(12):1087-95. (cited by 3 analyses) January 2008
• Plasma sitosterol elevations are associated with an increased incidence of coronary events in men: results of a nested case-control analysis of the Prospective Cardiovascular Münster (PROCAM) study. Nutr Metab Cardiovasc Dis 2006 Jan;16(1):13-21. (cited by 3 analyses) February 2011
• Glycemic control and coronary heart disease risk in persons with and without diabetes: the atherosclerosis risk in communities study. Arch. Intern. Med. 2005 Sep 12;165(16):1910-6. (cited by 2 analyses) November 2010
• Relationship between biomarkers of oxidized low-density lipoprotein, statin therapy, quantitative coronary angiography, and atheroma: volume observations from the REVERSAL (Reversal of Atherosclerosis with Aggressive Lipid Lowering) study. J. Am. Coll. Cardiol. 2008 Jul 1;52(1):24-32. (cited by 2 analyses) November 2011
• Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial. J. Am. Coll. Cardiol. 2009 Jun 9;53(23):2186-96. (cited by 2 analyses) November 2011
• Diet, lifestyle, and the etiology of coronary artery disease: the Cornell China study. Am. J. Cardiol. 1998 Nov 26;82(10):18T-21T. (cited by 2 analyses) August 2012
• Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Cardiovasc Diabetol 2008;7:18. (cited by 2 analyses) July 2010
• Effect of the Anti-Coronary Club program on coronary heart disease. Risk-factor status. JAMA 1966 Nov 7;198(6):597-604. (cited by 2 analyses) May 2009
• Nonatherosclerotic narrowing of the atrioventricular node artery and sudden death. J. Am. Coll. Cardiol. 1993 Jan;21(1):117-22. (cited by 2 analyses) June 2010
• A randomised controlled trial of Doppler ultrasound velocimetry of the umbilical artery in low risk pregnancies. Doppler French Study Group. Br J Obstet Gynaecol 1997 Apr;104(4):419-24. (cited by 2 analyses) July 2011
• Coronary arteries in fetuses, infants, and juveniles. Circulation 1957 Aug;16(2):263-7. (cited by 2 analyses) May 2010
• Genetic variants associated with Lp(a) lipoprotein level and coronary disease. N. Engl. J. Med. 2009 Dec 24;361(26):2518-28. (cited by 2 analyses) February 2010
• Acculturation and coronary heart disease in Japanese-Americans. Am. J. Epidemiol. 1976 Sep;104(3):225-47. (cited by 2 analyses) May 2011
• Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis. JAMA 2007 Feb 7;297(5):499-508. (cited by 2 analyses) June 2010
• Thyrotropin levels and risk of fatal coronary heart disease: the HUNT study. Arch. Intern. Med. 2008 Apr 28;168(8):855-60. (cited by 2 analyses) February 2009
• Is the size of low-density lipoprotein particles related to the risk of coronary heart disease? JAMA 2002 Feb 13;287(6):712-3. (cited by 2 analyses) September 2009
• Dietary prevention of coronary heart disease: the Finnish Mental Hospital Study. Int J Epidemiol 1979 Jun;8(2):99-118. (cited by 2 analyses) December 2010
• Young obese women with polycystic ovary syndrome have evidence of early coronary atherosclerosis. J. Clin. Endocrinol. Metab. 2007 Dec;92(12):4609-14. (cited by 2 analyses) July 2010
• Diet, serum cholesterol, and death from coronary heart disease. The Western Electric study. N. Engl. J. Med. 1981 Jan 8;304(2):65-70. (cited by 2 analyses) January 2011
• Effect of cholesterol-lowering diet on mortality from coronary heart-disease and other causes. A twelve-year clinical trial in men and women. Lancet 1972 Oct 21;2(7782):835-8. (cited by 2 analyses) December 2010
• AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute. J. Am. Coll. Cardiol. 2006 May 16;47(10):2130-9. (cited by 2 analyses) January 2011
• Intensive glucose-lowering therapy reduces cardiovascular disease events in veterans affairs diabetes trial participants with lower calcified coronary atherosclerosis. Diabetes 2009 Nov;58(11):2642-8. (cited by 2 analyses) December 2010
• Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. J. Clin. Invest. 1996 Jun 15;97(12):2917-23. (cited by 2 analyses) February 2010
• Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ 2013;346:e8707. (cited by 2 analyses) February 2013
• Association between erectile dysfunction and coronary artery disease. Role of coronary clinical presentation and extent of coronary vessels involvement: the COBRA trial. Eur. Heart J. 2006 Nov;27(22):2632-9. (cited by 1 analysis) April 2008
• Family history of premature coronary heart disease and coronary artery calcification: Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 2007 Aug 7;116(6):619-26. (cited by 1 analysis) October 2007
• Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease. N. Engl. J. Med. 2005 Jul 7;353(1):46-57. (cited by 1 analysis) April 2008
• Coronary artery disease as clogged pipes: a misconceptual model. Circ Cardiovasc Qual Outcomes 2013 Jan 1;6(1):129-32. (cited by 1 analysis) February 2013
• Dietary cholesterol and coronary artery disease: a systematic review. Curr Atheroscler Rep 2009 Nov;11(6):418-22. (cited by 1 analysis) April 2013
• Non-HDL cholesterol is strongly associated with coronary artery calcification in asymptomatic individuals. Atherosclerosis 2009 Jan;202(1):289-95. (cited by 1 analysis) January 2009
• Non-invasive screening for coronary artery disease: calcium scoring. Heart 2007 Dec;93(12):1620-9. (cited by 1 analysis) March 2008
• Subclinical coronary artery atherosclerosis in patients with erectile dysfunction. J. Am. Coll. Cardiol. 2005 Oct 18;46(8):1503-6. (cited by 1 analysis) April 2008
• Psychosocial predictors of coronary artery calcification progression in postmenopausal women. Psychosom Med 2011;73(9):789-94. (cited by 1 analysis) January 2012
• Apolipoprotein B but not LDL cholesterol is associated with coronary artery calcification in type 2 diabetic whites. Diabetes 2009 Aug;58(8):1887-92. (cited by 1 analysis) July 2009
• Insulin resistance independently predicts the progression of coronary artery calcification. Am. Heart J. 2009 May;157(5):939-45. (cited by 1 analysis) February 2010
• Change in alpha1 HDL concentration predicts progression in coronary artery stenosis. Arterioscler. Thromb. Vasc. Biol. 2003 May 1;23(5):847-52. (cited by 1 analysis) January 2009
• Decreased nocturnal synthesis of melatonin in patients with coronary artery disease. Int. J. Cardiol. 2003 May;89(1):103-7. (cited by 1 analysis) November 2008
• Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 2001 May;21(5):844-8. (cited by 1 analysis) August 2009
• Role of Chlamydia pneumoniae, helicobacter pylori and cytomegalovirus in coronary artery disease. Pak J Pharm Sci 2011 Apr;24(2):95-101. (cited by 1 analysis) May 2013
• Coronary artery calcification screening: estimated radiation dose and cancer risk. Arch. Intern. Med. 2009 Jul 13;169(13):1188-94. (cited by 1 analysis) July 2009
• Evidence that apolipoprotein(a) phenotype is a risk factor for coronary artery disease in men < 55 years of age. Am. J. Cardiol. 1994 Aug 15;74(4):346-51. (cited by 1 analysis) October 2008
• CARDIOVASCULAR STUDIES ON COPPER-DEFICIENT SWINE. V. THE HISTOGENESIS OF THE CORONARY ARTERY LESIONS. Am. J. Pathol. 1963 Dec;43:945-54. (cited by 1 analysis) April 2010
• Effects of cranberry juice consumption on vascular function in patients with coronary artery disease. Am. J. Clin. Nutr. 2011 May;93(5):934-40. (cited by 1 analysis) February 2012
• Abnormalities of cardiac autonomic nervous activity correlate with expansive coronary artery remodeling. Atherosclerosis 2008 Mar;197(1):183-9. (cited by 1 analysis) April 2008
• Inflammation, metabolic syndrome, erectile dysfunction, and coronary artery disease: common links. Eur. Urol. 2007 Dec;52(6):1590-600. (cited by 1 analysis) April 2008
• Association between erectile dysfunction and coronary artery disease: Matching the right target with the right test in the right patient. Eur. Urol. 2006 Oct;50(4):721-31. (cited by 1 analysis) April 2008
• Coronary artery calcium volume scores on electron beam tomography in 12,936 asymptomatic adults. Am. J. Cardiol. 2004 May 1;93(9):1146-9. (cited by 1 analysis) November 2007
• Influence of lipid-lowering therapy on the progression of coronary artery calcification: a prospective evaluation. Circulation 2002 Aug 27;106(9):1077-82. (cited by 1 analysis) November 2007
• High levels of Lp(a) with a small apo(a) isoform are associated with coronary artery disease in African American and white men. Arterioscler. Thromb. Vasc. Biol. 2000 Dec;20(12):2619-24. (cited by 1 analysis) October 2008
• Altered particle size distribution of apolipoprotein A-I-containing lipoproteins in subjects with coronary artery disease. J. Lipid Res. 1991 Mar;32(3):383-94. (cited by 1 analysis) July 2009
• C-reactive protein modulates vagal heart rate control in patients with coronary artery disease. Clin. Sci. 2007 Apr;112(8):449-56. (cited by 1 analysis) April 2008
• A protective anti-inflammatory phenotype in high-risk individuals who do not develop coronary artery disease. J. Am. Coll. Cardiol. 2006 Mar 7;47(5):1085-6. (cited by 1 analysis) January 2009
• High coronary artery calcium scores pose an extremely elevated risk for hard events. J. Am. Coll. Cardiol. 2002 Jan 16;39(2):225-30. (cited by 1 analysis) December 2008
• Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography. N. Engl. J. Med. 1998 Dec 31;339(27):1972-8. (cited by 1 analysis) December 2008
• Coronary artery disease: improved reproducibility of calcium scoring with an electron-beam CT volumetric method. Radiology 1998 Sep;208(3):807-14. (cited by 1 analysis) November 2010
• Angina pectoris induced by fat ingestion in patients with coronary artery disease; ballistocardiographic and electrocardiographic findings. J Am Med Assoc 1955 Jul 23;158(12):1008-13. (cited by 1 analysis) July 2011
• Relationships of abdominal obesity and hyperinsulinemia to angiographically assessed coronary artery disease in men with known mutations in the LDL receptor gene. Circulation 1998 Mar 10;97(9):871-7. (cited by 1 analysis) February 2010
• Effect of body mass index on early morbidity and mortality after isolated coronary artery bypass graft surgery. J. Cardiothorac. Vasc. Anesth. 2012 Oct;26(5):813-7. (cited by 1 analysis) January 2013
• Acute and chronic effects of exercise on inflammatory markers and B-type natriuretic peptide in patients with coronary artery disease. Clin Res Cardiol 2011 Jan;100(1):77-84. (cited by 1 analysis) January 2012
• Risk factors for the progression of coronary artery calcification in asymptomatic subjects: results from the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 2007 May 29;115(21):2722-30. (cited by 1 analysis) January 2008
• Adiponectin, visceral fat, oxidative stress, and early macrovascular disease: the Coronary Artery Risk Development in Young Adults Study. Obesity (Silver Spring) 2006 Feb;14(2):319-26. (cited by 1 analysis) February 2010
• Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial. JAMA 2009 Apr 15;301(15):1547-55. (cited by 1 analysis) April 2009
• Blood pressure and fasting plasma glucose rather than metabolic syndrome predict coronary artery calcium progression: the Rancho Bernardo Study. Diabetes Care 2009 Jan;32(1):141-6. (cited by 1 analysis) February 2010
• Characteristics of coronary artery disease and lipoprotein abnormalities in patients with heterozygous familial hypercholesterolemia associated with diabetes mellitus or impaired glucose tolerance. Atherosclerosis 1997 Jul 11;132(1):43-51. (cited by 1 analysis) August 2008
• Calcium begets calcium: progression of coronary artery calcification in asymptomatic subjects. Radiology 2002 Jul;224(1):236-41. (cited by 1 analysis) December 2008
• Leucocyte copper, a marker of copper body status is low in coronary artery disease. J Trace Elem Med Biol 2001;15(1):31-5. (cited by 1 analysis) April 2010
• Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: the Multi-Ethnic Study of Atherosclerosis (MESA). Arch. Intern. Med. 2008 Jun 23;168(12):1333-9. (cited by 1 analysis) July 2008
• The importance of serum lipoprotein (a) as an independent risk factor for premature coronary artery disease in middle-aged black and white women from the United States. J. Intern. Med. 1998 Nov;244(5):417-24. (cited by 1 analysis) October 2008
• Determinants of Progression of Coronary Artery Calcification in Type 2 Diabetes: Role of Glycemic Control and Inflammatory/Vascular Calcification Markers Journal of the American College of Cardi 2007 Dec;50(23):2218. (cited by 1 analysis) March 2008
• Risk factors for the metabolic syndrome: the Coronary Artery Risk Development in Young Adults (CARDIA) study, 1985-2001. Diabetes Care 2004 Nov;27(11):2707-15. (cited by 1 analysis) September 2010
• Effect of a mediterranean type of diet on the rate of cardiovascular complications in patients with coronary artery disease. Insights into the cardioprotective effect of certain nutriments. J. Am. Coll. Cardiol. 1996 Nov 1;28(5):1103-8. (cited by 1 analysis) June 2009
• Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation 2006 Jun 13;113(23):2733-43. (cited by 1 analysis) November 2009
• Change of energy expenditure from physical activity is the most powerful determinant of improved insulin sensitivity in overweight patients with coronary artery disease participating in an intensive lifestyle modification program. Metabolism: clinical and experimental 2011 Dec 5. (cited by 1 analysis) February 2012
• Effect of homocysteine-lowering B vitamin treatment on angiographic progression of coronary artery disease: a western norway B vitamin intervention trial (WENBIT) substudy. Am. J. Cardiol. 2010 Jun 1;105(11):1577-84. (cited by 1 analysis) July 2010
• Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians. Can J Cardiol 1997 Mar;13(3):253-60. (cited by 1 analysis) April 2008
• Coronary artery calcium scores and risk for cardiovascular events in women classified as "low risk" based on Framingham risk score: the multi-ethnic study of atherosclerosis (MESA). Arch. Intern. Med. 2007 Dec 10;167(22):2437-42. (cited by 1 analysis) July 2008
• Five-year follow-op of the medicine, angioplasty, or surgery study (MASS): A prospective, randomized trial of medical therapy, balloon angioplasty, or bypass surgery for single proximal left anterior descending coronary artery stenosis. Circulation 1999 Nov 9;100(19):II107-13. (cited by 1 analysis) September 2010
• Coronary calcium independently predicts incident premature coronary heart disease over measured cardiovascular risk factors: mean three-year outcomes in the Prospective Army Coronary Calcium (PACC) project. J. Am. Coll. Cardiol. 2005 Sep 6;46(5):807-14. (cited by 1 analysis) September 2008
• Differences in coronary plaque composition with aging measured by coronary computed tomography angiography. Int. J. Cardiol. 2012 Jul 12;158(2):240-5. (cited by 1 analysis) August 2012
• Running: the risk of coronary events : Prevalence and prognostic relevance of coronary atherosclerosis in marathon runners. Eur. Heart J. 2008 Aug;29(15):1903-10. (cited by 1 analysis) March 2011
• 17 beta-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation 1995 Jul 1;92(1):24-30. (cited by 1 analysis) July 2010